Hermann Gram Selected Research

Hermann Gram Research Topics

Disease

7	Inflammation (Inflammations) 10/2022 - 07/2005
6	Rheumatoid Arthritis 06/2012 - 07/2004
4	Atherosclerosis 10/2022 - 06/2012
4	Arthritis (Polyarthritis) 01/2020 - 07/2004
3	Myocardial Infarction 10/2022 - 01/2018
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2021 - 09/2014
3	Neoplasms (Cancer) 01/2020 - 02/2007
3	Experimental Arthritis 07/2005 - 08/2002
2	Infections 01/2020 - 01/2016
2	Fever (Fevers) 01/2020 - 01/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 06/2014
2	Cryopyrin-Associated Periodic Syndromes 09/2014 - 06/2012
1	Macrophage Activation Syndrome 11/2021
1	Rare Diseases (Rare Disease) 01/2020
1	Gout 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Fatigue 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Sepsis (Septicemia) 11/2016
1	Melioidosis 11/2016
1	Vascular Calcification 02/2016
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2016
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 06/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2012
1	Asthma (Bronchial Asthma) 06/2012
1	Stroke (Strokes) 06/2012
1	Dementia (Dementias) 06/2012
1	Brain Injuries (Brain Injury) 08/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2009
1	Insulin Resistance 11/2008
1	Type 2 Diabetes Mellitus (MODY) 11/2008
1	Body Weight (Weight, Body) 11/2008
1	Obesity 11/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2008
1	Shock 03/2008
1	Necrosis 03/2004

Drug/Important Bio-Agent (IBA)

7	canakinumab FDA Link 10/2022 - 01/2008
6	CytokinesIBA 10/2022 - 01/2008
5	Monoclonal AntibodiesIBA 10/2022 - 08/2006
4	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020 - 08/2009
4	Interleukin-1 (Interleukin 1)IBA 01/2019 - 07/2005
3	Apolipoproteins E (ApoE)IBA 10/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 06/2014
2	InflammasomesIBA 10/2022 - 11/2016
2	CholesterolIBA 10/2022 - 02/2016
2	Immunoglobulin G (IgG)IBA 01/2018 - 06/2009
2	AntibodiesIBA 01/2018 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2007
2	Messenger RNA (mRNA)IBA 11/2016 - 07/2005
2	AntigensIBA 06/2009 - 07/2005
2	Interleukin-1 Receptor-Associated KinasesIBA 06/2009 - 03/2008
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2008 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 08/2002
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 10/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	ianalumabIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CollagenIBA 01/2018
1	InterleukinsIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	B-Cell Activation Factor ReceptorIBA 06/2014
1	ApolipoproteinsIBA 06/2012
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2010
1	IntegrinsIBA 12/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	Eukaryotic Initiation Factor-4EIBA 12/2010
1	salicylhydroxamic acid (SHAM)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 06/2009
1	Dinoprostone (PGE2)FDA Link 11/2008
1	Interleukin-18 (Interleukin 18)IBA 11/2008
1	Imatinib Mesylate (Gleevec)FDA Link 10/2008
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2006
1	pyrimidineIBA 01/2006
1	PyrazinesIBA 01/2006
1	benzocycloheptapyridineIBA 01/2006
1	Interleukin-17 (Interleukin 17)IBA 07/2005
1	Proteoglycans (Proteoglycan)IBA 07/2005
1	ImidazolesIBA 07/2004
1	ThiazolesIBA 07/2004
1	BenzophenonesIBA 07/2004
1	PyridinesIBA 07/2004
1	OxazolesIBA 07/2004
1	DiureticsIBA 03/2004

Therapy/Procedure

3	Therapeutics 10/2022 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2019
1	Oral Administration 01/2006